David Nyman
Impact in
-
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
-
- Nanoparticle-Based Drug Delivery
Papers in
- Co-authors
- Kenneth A. Conrad (1 shared paper)Daniel D. Von Hoff (2 shared papers)Vuong Trieu (3 shared papers)Neil Desai (3 shared papers)Kelly M. Richardson (1 shared paper)Evan M. Hersh (1 shared paper)Kristen B. Long (1 shared paper)Michael Hawkins (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Blood (1 paper)Cell Biology and Toxicology (1 paper)Clinical Pharmacology & Therapeutics (1 paper)KTH Publication Database DiVA (KTH Royal Institute of Technology) (1 paper)
- Partner nations
- United States
In The Last Decade
David Nyman
7 papers receiving 381 citations
Peers
Comparison fields: 5 of 81
- Oncology 179
- Biomaterials 80
- Pharmacology 30
- Cancer Research 40
- Nutrition and Dietetics 35
Countries citing papers authored by David Nyman
This map shows the geographic impact of David Nyman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Nyman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Nyman more than expected).
Fields of papers citing papers by David Nyman
This network shows the impact of papers produced by David Nyman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Nyman. The network helps show where David Nyman may publish in the future.
Co-authors
The 21 scholars most cited alongside David Nyman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 230 | |
| 2 | 1980 | 81 | |
| 3 | 2004 | 44 | |
| 4 | 2002 | 30 | |
| 5 | 2004 | 9 | |
| 6 | 2004 | 2 | |
| 7 | 2005 | 2 | |
| 8 | Illegal fildelning i P2P-nätverk : ”Det är lugnt, du får bara böter” | 2006 | 1 |
About David Nyman
David Nyman is a scholar working on Genetics, Oncology, Hematology, Pathology and Forensic Medicine and Management Information Systems, having authored 8 papers that have together received 399 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Multiple Myeloma Research and Treatments (2 papers), Trace Elements in Health (1 paper), Prostate Cancer Treatment and Research (1 paper), FinTech, Crowdfunding, Digital Finance (1 paper), Prostate Cancer Diagnosis and Treatment (1 paper) and Heavy Metal Exposure and Toxicity (1 paper). The work is most often cited by research in Oncology (179 citations), Biomaterials (80 citations), Pharmacology (30 citations), Cancer Research (40 citations) and Nutrition and Dietetics (35 citations). David Nyman has collaborated with scholars based in United States. Frequent co-authors include Kenneth A. Conrad, Daniel D. Von Hoff, Vuong Trieu, Neil Desai, Kelly M. Richardson, Evan M. Hersh, Kristen B. Long, Michael Hawkins, Bruce L. Dalkin and A. Jay Gandolfi. Their work appears in journals such as Journal of Clinical Oncology, Blood, Cell Biology and Toxicology, Clinical Pharmacology & Therapeutics and KTH Publication Database DiVA (KTH Royal Institute of Technology).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.